Citations for
1PTPRD, PTPRF, PTPRS
LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain
Cornejo F, Cortés BI, Findlay GM, Cancino GI.
Front Cell Dev Biol. Dec 13;9:659951. doi: 10.3389/fcell.2021.659951. 2021
2IL1RAPL1, PTPRD
IL1RAPL1 knockout mice show spine density decrease, learning deficiency, hyperactivity and reduced anxiety-like behaviours.
Yasumura M, Yoshida T, Yamazaki M, Abe M, Natsume R, Kanno K, Uemura T, Takao K, Sakimura K, Kikusui T, Miyakawa T, Mishina M.
Sci Rep 4:6613. doi: 10.1038/srep06613. 2014
3PTPRD, PTPRS, SLITRK1, SLITRK2, SLITRK3, SLITRK4, SLITRK5, SLITRK6
Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases.
Yim YS, Kwon Y, Nam J, Yoon HI, Lee K, Kim DG, Kim E, Kim CH, Ko J.
Proc Natl Acad Sci U S A 110(10):4057-62. doi: 10.1073/pnas.1209881110. Epub 2013 Jan 23. 2013
4PTPRD
Functional analysis of the putative tumor suppressor PTPRD in neuroblastoma cells.
Clark O, Schmidt F, Coles CH, Tchetchelnitski V, Stoker AW.
Cancer Invest 30(5):422-32. 2012
5PTPRD
Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene.
Meehan M, Parthasarathi L, Moran N, Jefferies CA, Foley N, Lazzari E, Murphy D, Ryan J, Ortiz B, Fabius AW, Chan TA, Stallings RL.
Mol Cancer 11:6. 2012
6PTPRD
Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.
Lambert SR, Harwood CA, Purdie KJ, Gulati A, Matin RN, Romanowska M, Cerio R, Kelsell DP, Leigh IM, Proby CM.
Int J Cancer 131(3):E216-26. doi: 10.1002/ijc.27333. Epub 2011 Dec 21. 2012
7PTPRD, SLITRK3
Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction.
Takahashi H, Katayama K, Sohya K, Miyamoto H, Prasad T, Matsumoto Y, Ota M, Yasuda H, Tsumoto T, Aruga J, Craig AM.
Nat Neurosci 15(3):389-98, S1-2. doi: 10.1038/nn.3040. 2012
8CMIP, DCLK1, GRM8, PTPRD
Hearing function and thresholds: a genome-wide association study in European isolated populations identifies new loci and pathways.
Girotto G, Pirastu N, Sorice R, Biino G, Campbell H, d'Adamo AP, Hastie ND, Nutile T, Polasek O, Portas L, Rudan I, Ulivi S, Zemunik T, Wright AF, Ciullo M, Hayward C, Pirastu M, Gasparini P.
J Med Genet 48(6):369-74. doi: 10.1136/jmg.2010.088310. Epub 2011 Apr 14. 2011
9ARHGAP22, IL1RAPL1, IL1RAPL2, PTPRD
The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPδ and RhoGAP2.
Valnegri P, Montrasio C, Brambilla D, Ko J, Passafaro M, Sala C.
Hum Mol Genet 20(24):4797-809. Epub 2011 Sep 17. 2011
10PTPRD
High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma.
Giefing M, Zemke N, Brauze D, Kostrzewska-Poczekaj M, Luczak M, Szaumkessel M, Pelinska K, Kiwerska K, Tönnies H, Grenman R, Figlerowicz M, Siebert R, Szyfter K, Jarmuz M.
Genes Chromosomes Cancer 50(3):154-66. doi: 10.1002/gcc.20840. Epub 2010 Dec 7. 2011
11PTPRD
A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.
Kohno T, Otsuka A, Girard L, Sato M, Iwakawa R, Ogiwara H, Sanchez-Cespedes M, Minna JD, Yokota J.
Genes Chromosomes Cancer 49(4):342-52.PMID: 20073072 2010
12PTPRD
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, Pao W, Ladanyi M, Gerald WL, Liau L, Cloughesy TC, Mischel PS, Sander C, Taylor B, Schultz N, Major J, Heguy A, Fang F, Mellinghoff IK, Chan TA.
Proc Natl Acad Sci U S A 106(23):9435-40. Epub 2009 May 28. 2009
13PTPRD
Aberrant splicing of the PTPRD gene mimics microdeletions identified at this locus in neuroblastomas.
Nair P, Depreter K, Vandesompele J, Speleman F, Stallings RL.
Genes Chromosomes Cancer 47(3):197-202. 2008
14PTPRD, RLLS3
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome.
Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, Ripke S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Högl B, Frauscher B, Gschliesser V, Poewe W, Peglau I, Vodicka P, Vávrová J, Sonka K, Nevsimalova S, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann HE, Holsboer F, Müller-Myhsok B, Meitinger T, Winkelmann J.
Nat Genet 40(8):946-8. Epub 2008 Jul 27. 2008
15PTPRD
Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis.
Purdie KJ, Lambert SR, Teh MT, Chaplin T, Molloy G, Raghavan M, Kelsell DP, Leigh IM, Harwood CA, Proby CM, Young BD.
Genes Chromosomes Cancer 46(7):661-9. 2007
16PTPRD
High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma.
Stallings RL, Nair P, Maris JM, Catchpoole D, McDermott M, O'Meara A, Breatnach F.
Cancer Res 66(7):3673-80. 2006
17PTPRD, PTPRS
Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta.
Uetani N, Chagnon MJ, Kennedy TE, Iwakura Y, Tremblay ML.
J Neurosci 26(22):5872-80. 2006
18PTPRD
Chromosomal assignment of the gene for protein tyrosine phosphatase HPTP delta.
Hasegawa K, et al.
Jpn J Cancer Res 84 : 1219-1222. 1993
19PTPRA, PTPRB, PTPRD, PTPRE, PTPRG, PTPRZ1
Structural diversity and evolution of human receptor-like protein tyrosine phosphatases.
Krueger NX, et al.
Embo J 9 : 3241-3252. 1990